GINKGO BIOWORKS HOLDINGS, INC. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0a8aa7f9-e6bf-422b-b7f9-8414e42b87f7/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $170.2M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-012346 |
| FY 2024 | $227.0M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-007819 |
| FY 2023 | $251.5M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-008052 |
| FY 2022 | $477.7M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-007461 |
| FY 2021 | $313.8M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-004821 |
| FY 2020 | $76.7M | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-339586 |
| FY 2019 | $54.2M | 2019-01-01 – 2019-12-31 | evidence 0001193125-21-339586 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GINKGO BIOWORKS HOLDINGS, INC. — all facts · Net Income · Operating Income